830 related articles for article (PubMed ID: 12576866)
21. Differential metastasis-associated gene analysis of prostate carcinoma cells derived from primary tumor and spontaneous lymphatic metastasis in nude mice with orthotopic implantation of PC-3M cells.
Chu JH; Sun ZY; Meng XL; Wu JH; He GL; Liu GM; Jiang XR
Cancer Lett; 2006 Feb; 233(1):79-88. PubMed ID: 15885894
[TBL] [Abstract][Full Text] [Related]
22. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
Man YG; Gardner WA
Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
[TBL] [Abstract][Full Text] [Related]
23. Molecular mechanisms of cancer metastasis: tumor and host properties and the role of oncogenes and suppressor genes.
Nicolson GL
Curr Opin Oncol; 1991 Feb; 3(1):75-92. PubMed ID: 2043698
[TBL] [Abstract][Full Text] [Related]
24. Identification of a novel metastasis-suppressor region on human chromosome 12.
Luu HH; Zagaja GP; Dubauskas Z; Chen SL; Smith RC; Watabe K; Ichikawa Y; Ichikawa T; Davis EM; Le Beau MM; Rinker-Schaeffer CW
Cancer Res; 1998 Aug; 58(16):3561-5. PubMed ID: 9721861
[TBL] [Abstract][Full Text] [Related]
25. Editorial: potential clinical use of exploiting metastasis suppressor genes to regulate prostatic cancer.
Hendrix MJ
J Urol; 2003 Mar; 169(3):1134. PubMed ID: 12576867
[No Abstract] [Full Text] [Related]
26. Metastasis suppressor genes for prostate cancer.
Ichikawa T; Nihei N; Kuramochi H; Kawana Y; Killary AM; Rinker-SchaefferCW ; Barrett JC; Isaacs JT; Kugoh H; Oshimura M; Shimazaki J
Prostate Suppl; 1996; 6():31-5. PubMed ID: 8630227
[TBL] [Abstract][Full Text] [Related]
27. Suppression of prostate tumor cell growth in vivo by WT1, the Wilms' tumor suppressor gene.
Fraizer G; Leahy R; Priyadarshini S; Graham K; Delacerda J; Diaz M
Int J Oncol; 2004 Mar; 24(3):461-71. PubMed ID: 14767530
[TBL] [Abstract][Full Text] [Related]
28. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
Dobosy JR; Roberts JL; Fu VX; Jarrard DF
J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
[TBL] [Abstract][Full Text] [Related]
29. Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer.
Singh LS; Berk M; Oates R; Zhao Z; Tan H; Jiang Y; Zhou A; Kirmani K; Steinmetz R; Lindner D; Xu Y
J Natl Cancer Inst; 2007 Sep; 99(17):1313-27. PubMed ID: 17728215
[TBL] [Abstract][Full Text] [Related]
30. Genetic pathways of two types of gastric cancer.
Tahara E
IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
[TBL] [Abstract][Full Text] [Related]
31. Genetic and microenvironmental implications in prostate cancer progression and metastasis.
Alberti C
Eur Rev Med Pharmacol Sci; 2008; 12(3):167-75. PubMed ID: 18700688
[TBL] [Abstract][Full Text] [Related]
32. Metastasis signatures: genes regulating tumor-microenvironment interactions predict metastatic behavior.
Albini A; Mirisola V; Pfeffer U
Cancer Metastasis Rev; 2008 Mar; 27(1):75-83. PubMed ID: 18046511
[TBL] [Abstract][Full Text] [Related]
33. Metastasis-Associated genes and metastatic tumor progression.
Nicolson GL; Moustafa AS
In Vivo; 1998; 12(6):579-88. PubMed ID: 9891220
[TBL] [Abstract][Full Text] [Related]
34. Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread.
Narla G; DiFeo A; Yao S; Banno A; Hod E; Reeves HL; Qiao RF; Camacho-Vanegas O; Levine A; Kirschenbaum A; Chan AM; Friedman SL; Martignetti JA
Cancer Res; 2005 Jul; 65(13):5761-8. PubMed ID: 15994951
[TBL] [Abstract][Full Text] [Related]
35. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
36. ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK).
Aguirre-Ghiso JA; Estrada Y; Liu D; Ossowski L
Cancer Res; 2003 Apr; 63(7):1684-95. PubMed ID: 12670923
[TBL] [Abstract][Full Text] [Related]
37. The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer.
Bandyopadhyay S; Wang Y; Zhan R; Pai SK; Watabe M; Iiizumi M; Furuta E; Mohinta S; Liu W; Hirota S; Hosobe S; Tsukada T; Miura K; Takano Y; Saito K; Commes T; Piquemal D; Hai T; Watabe K
Cancer Res; 2006 Dec; 66(24):11983-90. PubMed ID: 17178897
[TBL] [Abstract][Full Text] [Related]
38. The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer.
Turley RS; Finger EC; Hempel N; How T; Fields TA; Blobe GC
Cancer Res; 2007 Feb; 67(3):1090-8. PubMed ID: 17283142
[TBL] [Abstract][Full Text] [Related]
39. Axis of evil: molecular mechanisms of cancer metastasis.
Bogenrieder T; Herlyn M
Oncogene; 2003 Sep; 22(42):6524-36. PubMed ID: 14528277
[TBL] [Abstract][Full Text] [Related]
40. Function and therapeutic implication of C-CAM cell-adhesion molecule in prostate cancer.
Lin SH; Pu YS
Semin Oncol; 1999 Apr; 26(2):227-33. PubMed ID: 10597733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
